Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the feasibility of performing EGBD as a treatment of acute calculous cholecystitis in patients that are indicated for laparoscopic cholecystectomy.
The gold standard for treatment of acute calculous cholecystitis is laparoscopic cholecystectomy. Recently, gallbladder drainage with EUS-guided gallbladder drainage (EGBD) has been described as a treatment option. However, whether this is an effective treatment option in surgically fit patients are uncertain.
The aim of the current study is to evaluate the feasibility of performing EGBD as a treatment of acute calculous cholecystitis in patients that are indicated for laparoscopic cholecystectomy. The investigators hypothesis that the technique is safe and feasible.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| EUS-guided gallbladder drainage (EGBD) | Experimental | The procedure would be performed with a linear echoendoscope using a 10mm x 10mm or a 15 x 10mm stent. The distal flange of the stent would be deployed under EUS guidance, followed by deployment of the proximal flange under endoscopic guidance. Once deployed, the gallbladder would be completely emptied by suction and irrigation until the effluent through the stent is clean. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| EUS-guided gallbladder drainage (EGBD) | Device | As listed in the arms description |
|
| Measure | Description | Time Frame |
|---|---|---|
| Clinical success rate | Complete resolution of acute cholecystitis as defined by resolution of fever, pain and change of white cell counts of 10% | 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Technical success rate | Defined as successful placement of a metal stent between the gallbladder and the duodenum or the stomach | 30 days |
| 30-day adverse events rate | Adverse events would be graded according to the lexicon of endoscopic adverse events |
Not provided
Inclusion Criteria:
Consecutive healthy patients aged ≥ 18 years old suffering from acute calculous cholecystitis indicated for laparoscopic cholecystectomy would be included.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anthony Teoh | CUHK | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chinese University of Hong Kong | Hong Kong | Hong Kong | China |
Not provided
| ID | Term |
|---|---|
| D041881 | Cholecystitis, Acute |
| D042882 | Gallstones |
| ID | Term |
|---|---|
| D002764 | Cholecystitis |
| D005705 | Gallbladder Diseases |
| D001660 | Biliary Tract Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 30 days |
| Stone or polyp recurrences | An ultrasonography of the abdomen would also be arranged yearly to check for recurrence of stones or polyps. | 3 years |
| Quality of life scores: Gastrointestinal quality of life index | Gastrointestinal quality of life index | 3 years |
| Mortality rate | Death from any cause | 3 years |
| Reintervention rate | The number of patients requiring biliary related re-interventions within 3 years. | 3 years |
| D002769 |
| Cholelithiasis |
| D041761 | Cholecystolithiasis |
| D002137 | Calculi |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |